Clinical Trials Browser

Phase 2 × plerixafor × 30 days × Clear all

NCT07605416 2026-05-26

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Phase 2 Not yet recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell